Open Orphan - hVIVO commences phase 1 clinical trials of Codagenix COVID-19 vaccine
ORPH Mon, 14 Dec 2020, 07:00am GMT
Open Orphan was founded in 2017, with the goal of becoming Europe’s leading rare disease and orphan drug focused pharma services company by a management team with extensive industry and financial expertise.
Industry: Health Care
Contact: +353 (01) 6440007
Dublin 2, Ireland